MedTrace Logo

the Effectiveness of Different Risk Scales In Predicting VTE in Respiratory Inpatients

NCT04963374 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2023-11-22

No results posted yet for this study

Summary

To compare the predictive effectiveness of the Caprini risk assessment model, the Padua risk assessment model and the VTE risk assessment in medical patients mentioned in the 2018 edition of the Guidelines for the diagnosis, treatment and prevention of pulmonary thromboembolism on the risk of concomitant VTE in respiratory inpatients to provide a basis for clinical VTE assessment and treatment.

Conditions

  • Venous Thromboembolism

Interventions

OTHER

risk evolution scale

Padua score、Caprini score、Prime score

Sponsors & Collaborators

  • Peking University Third Hospital

    lead OTHER

Principal Investigators

  • Jing Zhang, MD · Peking UTH

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-04-01
Primary Completion
2022-12-31
Completion
2022-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04963374 on ClinicalTrials.gov